| A serological assay to detect SARS-CoV-2 seroconversion in humans F Amanat, D Stadlbauer, S Strohmeier, THO Nguyen, V Chromikova, ... Nature medicine 26 (7), 1033-1036, 2020 | 2097 | 2020 |
| Robust neutralizing antibodies to SARS-CoV-2 infection persist for months A Wajnberg, F Amanat, A Firpo, DR Altman, MJ Bailey, M Mansour, ... Science 370 (6521), 1227-1230, 2020 | 1286 | 2020 |
| SARS‐CoV‐2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup D Stadlbauer, F Amanat, V Chromikova, K Jiang, S Strohmeier, ... Current protocols in microbiology 57 (1), e100, 2020 | 794 | 2020 |
| Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses MG Alameh, I Tombácz, E Bettini, K Lederer, S Ndeupen, C Sittplangkoon, ... Immunity 54 (12), 2877-2892. e7, 2021 | 470 | 2021 |
| A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice D Laczkó, MJ Hogan, SA Toulmin, P Hicks, K Lederer, BT Gaudette, ... Immunity 53 (4), 724-732. e7, 2020 | 364 | 2020 |
| A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial R Nachbagauer, J Feser, A Naficy, DI Bernstein, J Guptill, EB Walter, ... Nature medicine 27 (1), 106-114, 2021 | 290 | 2021 |
| SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 F Amanat, M Thapa, T Lei, SMS Ahmed, DC Adelsberg, JM Carreño, ... Cell 184 (15), 3936-3948. e10, 2021 | 270 | 2021 |
| Human germinal centres engage memory and naive B cells after influenza vaccination JS Turner, JQ Zhou, J Han, AJ Schmitz, AA Rizk, WB Alsoussi, T Lei, ... Nature 586 (7827), 127-132, 2020 | 256 | 2020 |
| Broadly protective human antibodies that target the active site of influenza virus neuraminidase D Stadlbauer, X Zhu, M McMahon, JS Turner, TJ Wohlbold, AJ Schmitz, ... Science 366 (6464), 499-504, 2019 | 227 | 2019 |
| Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection R Rathnasinghe, S Strohmeier, F Amanat, VL Gillespie, F Krammer, ... Emerging microbes & infections 9 (1), 2433-2445, 2020 | 190 | 2020 |
| An in vitro microneutralization assay for SARS‐CoV‐2 serology and drug screening F Amanat, KM White, L Miorin, S Strohmeier, M McMahon, P Meade, ... Current protocols in microbiology 58 (1), e108, 2020 | 187 | 2020 |
| Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA JE Oh, E Song, M Moriyama, P Wong, S Zhang, R Jiang, S Strohmeier, ... Science immunology 6 (66), eabj5129, 2021 | 142 | 2021 |
| SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months A Wajnberg, F Amanat, A Firpo, DR Altman, MJ Bailey, M Mansour, ... MedRxiv, 2020.07. 14.20151126, 2020 | 124 | 2020 |
| Broadly neutralizing antibodies target a haemagglutinin anchor epitope JJ Guthmiller, J Han, HA Utset, L Li, LYL Lan, C Henry, CT Stamper, ... Nature 602 (7896), 314-320, 2022 | 111 | 2022 |
| The neuraminidase of A (H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain H Wan, J Gao, H Yang, S Yang, R Harvey, YQ Chen, NY Zheng, J Chang, ... Nature microbiology 4 (12), 2216-2225, 2019 | 78 | 2019 |
| Sterilizing immunity against SARS‐CoV‐2 infection in mice by a single‐shot and lipid amphiphile imidazoquinoline TLR7/8 agonist‐adjuvanted recombinant spike protein vaccine S Jangra, J De Vrieze, A Choi, R Rathnasinghe, G Laghlali, A Uvyn, ... Angewandte Chemie International Edition 60 (17), 9467-9473, 2021 | 63 | 2021 |
| Human antibodies targeting influenza B virus neuraminidase active site are broadly protective A Madsen, YN Dai, M McMahon, AJ Schmitz, JS Turner, J Tan, T Lei, ... Immunity 53 (4), 852-863. e7, 2020 | 61 | 2020 |
| Mucosal immunity against neuraminidase prevents influenza B virus transmission in guinea pigs M McMahon, E Kirkpatrick, D Stadlbauer, S Strohmeier, NM Bouvier, ... MBio 10 (3), 10.1128/mbio. 00560-19, 2019 | 58 | 2019 |
| Introduction of two prolines and removal of the polybasic cleavage site lead to higher efficacy of a recombinant spike-based SARS-CoV-2 vaccine in the mouse model F Amanat, S Strohmeier, R Rathnasinghe, M Schotsaert, L Coughlan, ... MBio 12 (2), 10.1128/mbio. 02648-20, 2021 | 57 | 2021 |
| Influenza virus infection induces a narrow antibody response in children but a broad recall response in adults P Meade, G Kuan, S Strohmeier, HE Maier, F Amanat, A Balmaseda, K Ito, ... MBio 11 (1), 10.1128/mbio. 03243-19, 2020 | 57 | 2020 |
